enGene Holdings Inc.
ENGN
$5.56
$0.213.93%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 29.57% | 121.99% | 389.82% | 433.78% | 226.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.16% | 168.23% | 265.42% | 132.53% | 59.69% |
| Operating Income | -67.16% | -168.23% | -265.42% | -132.53% | -59.69% |
| Income Before Tax | 81.47% | -200.36% | -183.28% | -44.80% | -888.49% |
| Income Tax Expenses | 11.76% | -- | -- | -- | -22.73% |
| Earnings from Continuing Operations | 81.46% | -199.75% | -183.68% | -44.39% | -886.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 81.46% | -199.75% | -183.68% | -44.39% | -886.10% |
| EBIT | -67.16% | -168.23% | -265.42% | -132.53% | -59.69% |
| EBITDA | -67.73% | -168.77% | -266.64% | -133.12% | -60.21% |
| EPS Basic | 99.71% | 96.25% | 95.91% | 96.53% | -4,547.98% |
| Normalized Basic EPS | 99.07% | 87.35% | 95.01% | 96.07% | -1,528.90% |
| EPS Diluted | 99.71% | 96.25% | 95.91% | 96.53% | -4,547.98% |
| Normalized Diluted EPS | 99.07% | 87.35% | 95.01% | 96.07% | -1,528.90% |
| Average Basic Shares Outstanding | 6,168.18% | 6,198.16% | 5,579.45% | 3,462.89% | -80.78% |
| Average Diluted Shares Outstanding | 6,168.18% | 6,198.16% | 5,579.45% | 3,462.89% | -80.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
